Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
Year: 2020
Type: article
Authors: Julio A. Chirinos, Alena Orlenko, Lei Zhao, Michael D. Basso, Mary Ellen Cvijic, Zhuyin Li, Thomas E. Spires, Melissa Yarde, Zhaoqing Wang, Dietmar A. Seiffert, Stuart Prenner, Payman Zamani, Priyanka Bhattacharya, Anupam Kumar, Kenneth B. Margulies, Bruce D. Car, David A. Gordon, Jason H. Moore, Thomas P. Cappola
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: heart failure with preserved ejection fraction, plasma biomarkers, risk stratification, heart failure hospitalization, all-cause mortality, fibroblast growth factor 23, osteoprotegerin, inflammation, mineral metabolism, fibrosis, liver fibrosis, kidney injury, YKL-40, ST2, N-terminal pro-brain natriuretic peptide
Open Access status: bronze
Awards: Developing Oral LT3 Therapy for Heart Failure, VASCULAR EFFECTS OF DIETARY SALT IN HUMANS WITH SALT-RESISTANT BP, Bioinformatics Strategies for Genome Wide Association Studies, Understanding Racial Differences in Vascular Function and Ventricular-Vascular Coupling in Heart Failure with Preserved Ejection Fraction, Individual Differences in Obstructive Sleep Apnea, Genomics of myocardial transcription factors in cardiac remodeling, HFpEF: more than just the heart - Why the mitochondria and capillaries matter, Efficacy of Potassium Nitrate in Heart Failure with Preserved Ejection Fraction, Cardiovascular Risk after Preeclampsia - The CRISP study, Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal), MTSS1 in myocardial disease
OpenAlex ID: W3011669549
